相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Myeloid regulatory cells in tumor spreading and metastasis
Anton A. Keskinov et al.
IMMUNOBIOLOGY (2015)
Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy
Oana Draghiciu et al.
ONCOIMMUNOLOGY (2015)
The Alteration and Clinical Significance of Th1/Th2/Th17/Treg Cells in Patients with Multiple Myeloma
Ping Feng et al.
INFLAMMATION (2015)
MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth
Junfeng Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
Nicola Amodio et al.
Oncotarget (2015)
Predicting survival for multiple myeloma patients using baseline neutrophil/lymphocyte ratio
Engin Kelkitli et al.
ANNALS OF HEMATOLOGY (2014)
Treatment of Metastatic Colorectal Cancer With or Without Bevacizumab: Can the Neutrophil/Lymphocyte Ratio Predict the Efficiency of Bevacizumab?
Ahmet Dirican et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Signaling pathways involved in MDSC regulation
Prashant Trikha et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Simple Prognostic Score for Metastatic Castration-Resistant Prostate Cancer With Incorporation of Neutrophil-to-Lymphocyte Ratio
Arnoud J. Templeton et al.
CANCER (2014)
Regular Aspirin Use and Risk of Multiple Myeloma: A Prospective Analysis in the Health Professionals Follow-up Study and Nurses' Health Study
Brenda M. Birmann et al.
CANCER PREVENTION RESEARCH (2014)
Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells
Aaron P. Rapoport et al.
CLINICAL CANCER RESEARCH (2014)
G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent
Linda J. Bendall et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
microRNAs as potential regulators of myeloid-derived suppressor cell expansion
Mohamed El Gazzar
INNATE IMMUNITY (2014)
A p53-Dependent Tumor Suppressor Network Is Induced by Selective miR-125a-5p Inhibition in Multiple Myeloma Cells
Marzia Leotta et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Noncanonical NF-κB Activation Mediates STAT3-Stimulated IDO Upregulation in Myeloid-Derived Suppressor Cells in Breast Cancer
Jinpu Yu et al.
JOURNAL OF IMMUNOLOGY (2014)
MicroRNA-155 and MicroRNA-21 Promote the Expansion of Functional Myeloid-Derived Suppressor Cells
Limin Li et al.
JOURNAL OF IMMUNOLOGY (2014)
Gemcitabine, Oxaliplatin, Levofolinate, 5-Fluorouracil, Granulocyte-Macrophage Colony-Stimulating Factor, and Interleukin-2 (GOLFIG) Versus FOLFOX Chemotherapy in Metastatic Colorectal Cancer Patients: The GOLFIG-2 Multicentric Open-label Randomized Phase III Trial
Pierpaolo Correale et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors
Daniel W. Beury et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma
James Favaloro et al.
LEUKEMIA & LYMPHOMA (2014)
Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
Hong Qin et al.
NATURE MEDICINE (2014)
Roles of miRNAs in regulating the differentiation and maturation of myeloid-derived suppressor cells
Jie Tian et al.
MEDICAL HYPOTHESES (2014)
Long non-coding RNAs in the regulation of the immune response
James A. Heward et al.
TRENDS IN IMMUNOLOGY (2014)
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity
Lavinia Raimondi et al.
ONCOTARGET (2014)
Immunological Dysregulation in Multiple Myeloma Microenvironment
Alessandra Romano et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Targeting Immune Suppression with PDE5 Inhibition in End-Stage Multiple Myeloma
Kimberly A. Noonan et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Evolution of our understanding of myeloid regulatory cells: from MDSCs to Mregs
Masoud H. Manjili et al.
FRONTIERS IN IMMUNOLOGY (2014)
Chemotherapeutic targeting of myeloid-derived suppressor cells
Darya Alizadeh et al.
ONCOIMMUNOLOGY (2014)
Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans
Guellue Topal Goerguen et al.
BLOOD (2013)
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients
Cirino Botta et al.
CANCER BIOLOGY & THERAPY (2013)
Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
Cristina Iclozan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Myeloid-Derived Suppressor Cells Function as Novel Osteoclast Progenitors Enhancing Bone Loss in Breast Cancer
Anandi Sawant et al.
CANCER RESEARCH (2013)
miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells
Nicola Amodio et al.
CELL CYCLE (2013)
Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth
Emanuela Leone et al.
CLINICAL CANCER RESEARCH (2013)
New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors
Michele Cea et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
MicroRNAs in the tumour microenvironment: big role for small players
Patsy Soon et al.
ENDOCRINE-RELATED CANCER (2013)
Immunologic microenvironment and personalized treatment in multiple myeloma
Marco Rossi et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Myeloid-derived suppressor cells in cancer: recent progress and prospects
Yazan S. Khaled et al.
IMMUNOLOGY AND CELL BIOLOGY (2013)
MicroRNAs Involved in Anti-Tumour Immunity
Hong W. H. Yu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
MicroRNAs: Essential players in the regulation of inflammation
Ana Rebane et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
miR-29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma-related bone disease
Marco Rossi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling
Natasa Obermajer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Myeloid-Derived Suppressor Cells Regulate Growth of Multiple Myeloma by Inhibiting T Cells in Bone Marrow
Indu R. Ramachandran et al.
JOURNAL OF IMMUNOLOGY (2013)
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer
Je-In Youn et al.
NATURE IMMUNOLOGY (2013)
The Systemic Cytokine Environment Is Permanently Altered in Multiple Myeloma
Mary M. Zheng et al.
PLOS ONE (2013)
Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients with Colorectal Carcinoma
Bin Zhang et al.
PLOS ONE (2013)
Role of microRNAs in the immune system, inflammation and cancer
Jennifer Raisch et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance
C. Bryant et al.
BLOOD CANCER JOURNAL (2013)
A MicroRNA Component of the Neoplastic Microenvironment: Microregulators with Far-Reaching Impact
Xiaolei Li et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Myeloid-Derived Suppressor Cells Interact with Tumors in Terms of Myelopoiesis, Tumorigenesis and Immunosuppression: Thick as Thieves
Alexandra Sevko et al.
JOURNAL OF CANCER (2013)
MicroRNAs as novel immunotherapeutics
Amy B. Heimberger et al.
ONCOIMMUNOLOGY (2013)
Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer
Robert Wesolowski et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2013)
Multiple Myeloma Macrophages: Pivotal Players in the Tumor Microenvironment
Simona Berardi et al.
JOURNAL OF ONCOLOGY (2013)
History of myeloid-derived suppressor cells
James E. Talmadge et al.
NATURE REVIEWS CANCER (2013)
Increased IL-17 production correlates with immunosuppression involving myeloid-derived suppressor cells and nutritional impairment in patients with various gastrointestinal cancers
Takashi Yazawa et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells
Jaehyup Kim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth
Matthew R. Porembka et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Aptamer-Mediated Blockade of IL4Rα Triggers Apoptosis of MDSCs and Limits Tumor Progression
Felix Roth et al.
CANCER RESEARCH (2012)
Myeloid-Derived Suppressor Cells Participate in Preventing Graft Rejection
Yan Wang et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Tumor Infiltration by T Lymphocytes Expressing Chemokine Receptor 7 (CCR7) Is Predictive of Favorable Outcome in Patients with Advanced Colorectal Carcinoma
Pierpaolo Correale et al.
CLINICAL CANCER RESEARCH (2012)
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
Maria T. Di Martino et al.
CLINICAL CANCER RESEARCH (2012)
Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma
P. Tagliaferri et al.
CURRENT CANCER DRUG TARGETS (2012)
Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma
P. Tassone et al.
CURRENT CANCER DRUG TARGETS (2012)
Myeloid-Derived Suppressor Cells and anti-tumor T cells: a complex relationship
Ngozi R. Monu et al.
IMMUNOLOGICAL INVESTIGATIONS (2012)
Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro
P. Correale et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
Pasquale Sansone et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Mouse CD11b+Gr-1+ Myeloid Cells Can Promote Th17 Cell Differentiation and Experimental Autoimmune Encephalomyelitis
Huanfa Yi et al.
JOURNAL OF IMMUNOLOGY (2012)
MicroRNA-494 Is Required for the Accumulation and Functions of Tumor-Expanded Myeloid-Derived Suppressor Cells via Targeting of PTEN
Yang Liu et al.
JOURNAL OF IMMUNOLOGY (2012)
Immune-modulating Effects of the Newest Cetuximab-based Chemoimmunotherapy Regimen in Advanced Colorectal Cancer Patients
Cirino Botta et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells
Sara M. Centuori et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Multiple myeloma induces the immunosuppressive capacity of distinct myeloid-derived suppressor cell subpopulations in the bone marrow
E. Van Valckenborgh et al.
LEUKEMIA (2012)
Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer
Shinji Ohki et al.
ONCOLOGY REPORTS (2012)
Osteoclasts in Multiple Myeloma Are Derived from Gr-1+CD11b+Myeloid-Derived Suppressor Cells
Junling Zhuang et al.
PLOS ONE (2012)
Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells
Srinivas Nagaraj et al.
SEMINARS IN CANCER BIOLOGY (2012)
Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
Suzanne Ostrand-Rosenberg et al.
SEMINARS IN CANCER BIOLOGY (2012)
Correlation between circulating myeloid-derived suppressor cells and Th17 cells in esophageal cancer
Zhi-Jun Jiao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Tumor infiltration by chemokine receptor 7 (CCR7)+ T-lymphocytes is a favorable prognostic factor in metastatic colorectal cancer
Pierpaolo Correale et al.
ONCOIMMUNOLOGY (2012)
Generation of myeloid-derived suppressor cells using prostaglandin E-2
Natasa Obermajer et al.
TRANSPLANTATION RESEARCH (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling
Maria T. Di Martino et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Myeloid derived suppressor cells in human diseases
Tim F. Greten et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
miR-223 suppresses differentiation of tumor-induced CD11b+Gr1+myeloid-derived suppressor cells from bone marrow cells
Qiaofei Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
Tangying Lu et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Both miR-17-5p and miR-20a Alleviate Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating STAT3 Expression
Miaomiao Zhang et al.
JOURNAL OF IMMUNOLOGY (2011)
Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties
Sven Brandau et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Functional characterization of human Cd33+ And Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines
Melissa G. Lechner et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells
T. Calimeri et al.
LEUKEMIA (2011)
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes
Monica Marra et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism
Jeremy D. Waight et al.
PLOS ONE (2011)
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
Thomas Condamine et al.
TRENDS IN IMMUNOLOGY (2011)
STAT3 controls myeloid progenitor growth during emergency granulopoiesis
Huiyuan Zhang et al.
BLOOD (2010)
A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma
Kimberly Noonan et al.
BLOOD (2010)
Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma
Rao H. Prabhala et al.
BLOOD (2010)
COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
Joris D. Veltman et al.
BMC CANCER (2010)
Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer
Ping-Ying Pan et al.
CANCER RESEARCH (2010)
Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
Minu K. Srivastava et al.
CANCER RESEARCH (2010)
Myeloid-derived suppressor cell heterogeneity and subset definition
Elisa Peranzoni et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor
Ilaria Marigo et al.
IMMUNITY (2010)
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
Cesar A. Corzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Characterization of Cytokine-Induced Myeloid-Derived Suppressor Cells from Normal Human Peripheral Blood Mononuclear Cells
Melissa G. Lechner et al.
JOURNAL OF IMMUNOLOGY (2010)
Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
Srinivas Nagaraj et al.
JOURNAL OF IMMUNOLOGY (2010)
Subsets, expansion and activation of myeloid-derived suppressor cells
Eliana Ribechini et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2010)
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes
Marcin Kowanetz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR-/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma
M. K. Brimnes et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2010)
BIOMEDICAL RESEARCH Immunology Uncaged
Mitch Leslie
SCIENCE (2010)
Development and Function of Myeloid-Derived Suppressor Cells Generated From Mouse Embryonic and Hematopoietic Stem Cells
Zuping Zhou et al.
STEM CELLS (2010)
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
Mariateresa Fulciniti et al.
BLOOD (2009)
Arginase I-Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
Paulo C. Rodriguez et al.
CANCER RESEARCH (2009)
A High-Affinity Fully Human Anti-IL-6 mAb, 1339, for the Treatment of Multiple Myeloma
Mariateresa Fulciniti et al.
CLINICAL CANCER RESEARCH (2009)
Cutting the Limits of Aminobisphosphonates: New Strategies for the Potentiation of their Anti-Tumour Effects
M. Marra et al.
CURRENT CANCER DRUG TARGETS (2009)
Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation
Alberto Mantovani et al.
HUMAN IMMUNOLOGY (2009)
Fas Signal Promotes Lung Cancer Growth by Recruiting Myeloid-Derived Suppressor Cells via Cancer Cell-Derived PGE2
Yongliang Zhang et al.
JOURNAL OF IMMUNOLOGY (2009)
Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells
Erica M. Hanson et al.
JOURNAL OF IMMUNOLOGY (2009)
Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component
John A. Lust et al.
MAYO CLINIC PROCEEDINGS (2009)
G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models
Farbod Shojaei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implications
Kenji Ishitsuka et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor
Paola Neri et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells
Paolo Serafini et al.
CANCER RESEARCH (2008)
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives
Paulo C. Rodriguez et al.
IMMUNOLOGICAL REVIEWS (2008)
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
Pingyan Cheng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Subsets of myeloid-derived suppressor cells in tumor-bearing mice
Je-In Youn et al.
JOURNAL OF IMMUNOLOGY (2008)
Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma
P. Neri et al.
LEUKEMIA (2007)
Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma
Cecilia Melani et al.
CANCER RESEARCH (2007)
Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells
Yulia Nefedova et al.
CANCER RESEARCH (2007)
Neutralizing B-cell-activating factor antibody improves survival and inhibits osteoclastogenesis in a severe combined Immunodeficient human multiple myeloma model
Paola Neri et al.
CLINICAL CANCER RESEARCH (2007)
Targeting MEK induces myelorna-cell cytotoxicity and inhibits osteoclastogenesis
Yu-Tzu Tai et al.
BLOOD (2007)
Establishment of BCWM.1 cell line for Waldenstrom's macroglobulinemia with productive in vivo engraftment in SCID-hu mice
Daniel Ditzel Santos et al.
EXPERIMENTAL HEMATOLOGY (2007)
Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses
Ingo Fricke et al.
CLINICAL CANCER RESEARCH (2007)
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Farbod Shojaei et al.
NATURE BIOTECHNOLOGY (2007)
MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation
Laura Fontana et al.
NATURE CELL BIOLOGY (2007)
Altered macrophage differentiation and immune dysfunction in tumor development
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
MLN120B, a novel IκB kinase β inhibitor, blocks multiple myeloma cell growth in vitro and in vivo
Teru Hideshima et al.
CLINICAL CANCER RESEARCH (2006)
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
Giovanna Gallina et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
B Huang et al.
CANCER RESEARCH (2006)
Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression
SK Bunt et al.
JOURNAL OF IMMUNOLOGY (2006)
Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis
P Sinha et al.
CANCER RESEARCH (2005)
A minicircuitry comprised of MicroRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis
F Fazi et al.
CELL (2005)
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
PC Rodriguez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
A SCID-hu in vivo model of human Waldenstrom macroglobulinemia
P Tassone et al.
BLOOD (2005)
Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma
P Tassone et al.
CLINICAL CANCER RESEARCH (2005)
STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2005)
Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2004)
The farnesyl transferase inhibitor R115777 (Zarnestra®) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa®) and Pamidronate
M Caraglia et al.
ONCOGENE (2004)
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses
PC Rodriguez et al.
CANCER RESEARCH (2004)
Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ multiple myeloma cells
P Tassone et al.
BLOOD (2004)
Sustained exposure to bacterial antigen induces interferon-γ-dependent T cell receptor down-regulation and impaired T cell function
N Bronstein-Sitton et al.
NATURE IMMUNOLOGY (2003)
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients:: assessment of the most important laboratory indexes of cachexia and oxidative stress
G Mantovani et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2003)
Induction of γδ T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo
F Dieli et al.
BLOOD (2003)
Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro
P Tassone et al.
BRITISH JOURNAL OF CANCER (2003)
Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: Abrogation prevents tumor recurrence
M Terabe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice
V Bronte et al.
JOURNAL OF IMMUNOLOGY (2003)
Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand
B Heissig et al.
CELL (2002)
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism
A Mazzoni et al.
JOURNAL OF IMMUNOLOGY (2002)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines
P Tassone et al.
LEUKEMIA (2000)
分享论文
